Leadinno Medical Valley
Beijing-based medical device developer (founded 2016) focused on externally powered implantable neuromodulation platforms and rigid spinal endoscopy systems. Core activities include system and platform engineering for externally powered spinal cord and peripheral nerve stimulation implants (external power transmitters, implant power harvesting and demodulation, stimulation-drive electronics, and embedded firmware), domestic design and production of rigid endoscopic visualization systems and reusable instrument sets, recurring nationwide clinical training and multi-site live surgical broadcasting, an active patent portfolio on wireless power and implant communications, and institutional financing to support R&D and manufacturing scale-up. Company materials state goals to complete domestic regulatory registration for spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) within a multi-year timeframe and to expand the platform coverage to additional neuromodulation indications (including DBS and VNS).
Industries
Nr. of Employees
Very Large (1000+)
Products
Externally powered spinal cord stimulation system (battery-less)
Externally powered spinal stimulation system composed of an external control and power transmission unit and an implanted stimulation module that demodulates transmitted energy and delivers stimulation to spinal electrodes; designed to avoid an implanted battery and to support single-stage minimally invasive electrode implantation. Company materials report progression toward clinical-trial initiation.
Externally powered peripheral nerve stimulation device (in development)
Peripheral nerve stimulation device built on the externally powered implant platform intended for peripheral nerve modulation therapies; reported as under development with planned regulatory submissions.
Rigid spinal endoscopy systems and instrument sets
Foraminoscopic/transforaminal and dual-channel rigid endoscopy platforms and instrument sets for minimally invasive spine procedures; reported as certified for sale in China and used in clinical demonstrations and training.
Interlaminar and larger-channel endoscopy system variants (pipeline)
Interlaminar and larger-channel endoscopic system variants planned for domestic certification and market release, with company materials projecting regulatory clearance for additional models.
Externally powered spinal cord stimulation system (battery-less)
Externally powered spinal stimulation system composed of an external control and power transmission unit and an implanted stimulation module that demodulates transmitted energy and delivers stimulation to spinal electrodes; designed to avoid an implanted battery and to support single-stage minimally invasive electrode implantation. Company materials report progression toward clinical-trial initiation.
Externally powered peripheral nerve stimulation device (in development)
Peripheral nerve stimulation device built on the externally powered implant platform intended for peripheral nerve modulation therapies; reported as under development with planned regulatory submissions.
Rigid spinal endoscopy systems and instrument sets
Foraminoscopic/transforaminal and dual-channel rigid endoscopy platforms and instrument sets for minimally invasive spine procedures; reported as certified for sale in China and used in clinical demonstrations and training.
Interlaminar and larger-channel endoscopy system variants (pipeline)
Interlaminar and larger-channel endoscopic system variants planned for domestic certification and market release, with company materials projecting regulatory clearance for additional models.
Services
Organization and delivery of combined onsite and remote training including lectures, hands-on specimen/simulation practice and multi-site live surgical broadcasts supported by streaming infrastructure and remote classroom operations; recurring programs and salon series across multiple provinces.
Domestic production capability with production quality workflows, incoming material inspection, product testing and post‑market repair and maintenance services for rigid spinal endoscopy systems and reusable instrument sets.
Regulatory planning and dossier preparation for product certification and staged market entry in the Chinese regulatory environment, including preparation for clinical trial submissions for externally powered neuromodulation products.
Coordination with clinical centers for product evaluation, live-case support, surgical demonstration logistics and clinical feedback collection to support product development and training.
Participation in national medical device exhibitions and academic conferences to engage distributors and clinicians, demonstrate products and support channel development.
Organization and delivery of combined onsite and remote training including lectures, hands-on specimen/simulation practice and multi-site live surgical broadcasts supported by streaming infrastructure and remote classroom operations; recurring programs and salon series across multiple provinces.
Domestic production capability with production quality workflows, incoming material inspection, product testing and post‑market repair and maintenance services for rigid spinal endoscopy systems and reusable instrument sets.
Regulatory planning and dossier preparation for product certification and staged market entry in the Chinese regulatory environment, including preparation for clinical trial submissions for externally powered neuromodulation products.
Coordination with clinical centers for product evaluation, live-case support, surgical demonstration logistics and clinical feedback collection to support product development and training.
Participation in national medical device exhibitions and academic conferences to engage distributors and clinicians, demonstrate products and support channel development.
Expertise Areas
- Externally powered implantable neuromodulation
- RF-based wireless power transfer and implant communication
- Mixed-signal and stimulation ASIC design
- Embedded firmware and device-control software
Key Technologies
- RF/inductive wireless power transfer
- RF communication and energy demodulation circuitry
- Mixed-signal stimulation ASICs
- Implantable stimulation electronics
News & Updates
Multiple recurring training programs and microinvasive spine forums combining lectures, specimen/simulation practice and multi-site live surgical demonstrations supported by company-provided streaming infrastructure; reported single-event online viewership across events ranges from tens of thousands to over 260,000 depending on the event and year.
Exhibition and product demonstrations at major shows and academic meetings (including CMEF and specialty conferences) to engage distributors and clinicians and to present rigid endoscopy systems and surgical instrument sets.
Series of regionally held training courses, hands-on specimen workshops and live surgical demonstrations conducted across multiple Chinese provinces, organized or co-organized with hospitals and medical associations.
Company disclosed completion of an A-round reported to exceed RMB 100 million. Disclosed proceeds are allocated to neuromodulation R&D, production capacity expansion and company operations.
Public disclosures reference completion of an A+ financing round following earlier institutional rounds; proceeds allocated to spinal and neuromodulation product R&D, manufacturing scale-up and company operations.
Company announced completion of a Pre-A financing round reported in the low-to-mid tens of millions RMB, with participation from institutional investors; disclosed proceeds to accelerate R&D, patents and regulatory activities.
Multiple recurring training programs and microinvasive spine forums combining lectures, specimen/simulation practice and multi-site live surgical demonstrations supported by company-provided streaming infrastructure; reported single-event online viewership across events ranges from tens of thousands to over 260,000 depending on the event and year.
Exhibition and product demonstrations at major shows and academic meetings (including CMEF and specialty conferences) to engage distributors and clinicians and to present rigid endoscopy systems and surgical instrument sets.
Series of regionally held training courses, hands-on specimen workshops and live surgical demonstrations conducted across multiple Chinese provinces, organized or co-organized with hospitals and medical associations.
Company disclosed completion of an A-round reported to exceed RMB 100 million. Disclosed proceeds are allocated to neuromodulation R&D, production capacity expansion and company operations.
Public disclosures reference completion of an A+ financing round following earlier institutional rounds; proceeds allocated to spinal and neuromodulation product R&D, manufacturing scale-up and company operations.
Company announced completion of a Pre-A financing round reported in the low-to-mid tens of millions RMB, with participation from institutional investors; disclosed proceeds to accelerate R&D, patents and regulatory activities.